69
Participants
Start Date
September 6, 2017
Primary Completion Date
April 26, 2019
Study Completion Date
June 1, 2020
Placebo
oral tablets
CB-839
oral tablets
everolimus
oral tablets
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx
NYU Winthrop Hospital - Cancer Clinical Trials Oncology/Hematology, Mineola
North Shore Hematology Oncology Associates PC DBA NY Cancer and Blood Specialists, East Setauket
SUNY Upstate Medical University, Syracuse
Monongahela Valley Hospital, Monongahela
Ann B. Barshinger Cancer Institute / Lancaster General Hospital, Lancaster
University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
Anne Arundel Medical Center Oncology and Hematology, Annapolis
Charleston Hematology Oncology Associates,PA, Charleston
Northwest Georgia Oncology Centers, P.C., Marietta
University Cancer & Blood Center, LLC, Athens
Florida Cancer Specialists- North, St. Petersburg
Florida Cancer Specialists- South, Fort Myers
Sarah Cannon Research Institute - Tennessee Oncology, Nashville
UT/Erlanger Oncology & Hematology, Chattanooga
Norton Cancer Institute, Norton Healthcare Pavilion, Louisville
University of Cincinnati Medical Center, Cincinnati
Parkview Research Center, Fort Wayne
University of Iowa Hospitals and Clinics, Iowa City
University of Wisconsin Carbone Cancer Center, Madison
Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park
St. Vincent Frontier Cancer Center, Billings
Northwestern University, Chicago
Washington University School of Medicine, St Louis
SCRI HCA Midwest, Kansas City
Mercy Clinic Oncology & Hematology, Joplin
Ochsner Clinical Foundation, New Orleans
Highlands Oncology Group, Rogers
The University of Texas MD Anderson Cancer Center, Houston
St. Luke's Mountain States Tumor Institute, Boise
Utah Cancer Specialists, Salt Lake City
The University of Arizona Cancer Center, Tucson
Comprehensive Cancer Centers of Nevada, Las Vegas
Los Angeles Hematology Oncology Medical Group, Los Angeles
UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Stanford Cancer Center, Stanford
Wenatchee Valley Hospital and Clinics, Wenatchee
Lead Sponsor
Calithera Biosciences, Inc
INDUSTRY